{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:28:14Z","timestamp":1793633294270,"version":"4.5.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024601","name":"\u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Debreceni Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017507","name":"Department of Laboratory Medicine and Pathology, University of Washington","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.thromres.2026.109607","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:51:24Z","timestamp":1770252684000},"page":"109607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["IgM-enriched immunoglobulin treatment significantly improves coagulation dysbalance in an experimental animal model of fulminant sepsis"],"prefix":"10.1016","volume":"259","author":[{"given":"Ildik\u00f3","family":"Beke Debreceni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Krajcsir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m Attila","family":"M\u00e1trai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Ujhelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"P\u00f3csi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy J\u00e1zon","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"B\u00e9la","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"De\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"F\u00fclesdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Kappelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.thromres.2026.109607_bb0005","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10408363.2013.764490","article-title":"Biomarkers of sepsis","volume":"50","author":"Faix","year":"2013","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.thromres.2026.109607_bb0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.thromres.2026.109607_bb0020","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.thromres.2026.109607_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/1076029613509476","article-title":"Dysregulation of inflammatory and hemostatic markers in sepsis and suspected disseminated intravascular coagulation","volume":"21","author":"Hoppensteadt","year":"2015","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2026.109607_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb. Res."},{"issue":"10141","key":"10.1016\/j.thromres.2026.109607_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13613-020-00740-1","article-title":"Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis","volume":"10","author":"Nierhaus","year":"2020","journal-title":"Ann. Intensive Care"},{"issue":"21","key":"10.1016\/j.thromres.2026.109607_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216887","article-title":"Sepsis outcome after major abdominal surgery does not seem to be improved by the use of pentameric immunoglobulin IgM: a single-center retrospective analysis","volume":"12","author":"Perrella","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.thromres.2026.109607_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcrc.2015.02.012","article-title":"Intravenous immunoglobulin improves sepsis-induced coagulopathy: a retrospective, single-center observational study","volume":"30","author":"Ishikura","year":"2015","journal-title":"J. Crit. Care"},{"issue":"8","key":"10.1016\/j.thromres.2026.109607_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160907","article-title":"IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis: a before-after cohort study","volume":"11","author":"Wand","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2026.109607_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.717349","article-title":"Effect of intravenous IgM-enriched immunoglobulins on presepsin and other sepsis biomarkers","volume":"12","author":"Scarpati","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.thromres.2026.109607_bb0065","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/ijp.ijp_881_20","article-title":"Pentaglobin (immunoglobulin M-enriched immunoglobulin) as adjuvant therapy for premature and very low-birth-weight neonates with sepsis","volume":"53","author":"Nassir","year":"2021","journal-title":"Indian J. Pharmacol."},{"issue":"6","key":"10.1016\/j.thromres.2026.109607_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab169","article-title":"Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis","volume":"8","author":"Cilloniz","year":"2021","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2026.109607_bb0075","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/147323001204000337","article-title":"The effects of adjuvant immunoglobulin M-enriched immunoglobulin therapy on mortality rate and renal function in sepsis-induced multiple organ dysfunction syndrome: retrospective analysis of intensive care unit patients","volume":"40","author":"Yavuz","year":"2012","journal-title":"J. Int. Med. Res."},{"issue":"12","key":"10.1016\/j.thromres.2026.109607_bb0080","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s00134-014-3474-6","article-title":"Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock","volume":"40","author":"Cavazzuti","year":"2014","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13613-018-0466-7","article-title":"Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients","volume":"8","author":"Berlot","year":"2018","journal-title":"Ann. Intensive Care"},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13613-019-0609-5","article-title":"IgM-enriched immunoglobulins (Pentaglobin) may improve the microcirculation in sepsis: a pilot randomized trial","volume":"9","author":"Domizi","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.thromres.2026.109607_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thromres.2017.07.030","article-title":"Characteristics of thrombin generation in a fulminant porcine sepsis model","volume":"158","author":"T\u00f3th","year":"2017","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.thromres.2014.11.001","article-title":"Ex vivo thrombin generation patterns in septic patients with and without disseminated intravascular coagulation","volume":"135","author":"Carlier","year":"2015","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2026.109607_bb0105","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1097\/01.CCM.0000230382.38989.4F","article-title":"Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats","volume":"34","author":"Asakura","year":"2006","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.thromres.2026.109607_bb0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/CH-170271","article-title":"Red blood cell and platelet parameters are sepsis predictors in an Escherichia coli induced lethal porcine model","volume":"66","author":"T\u00f3th","year":"2017","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"3","key":"10.1016\/j.thromres.2026.109607_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/SHK.0000000000000509","article-title":"Circulating microparticles, blood cells, and endothelium induce procoagulant activity in sepsis through phosphatidylserine exposure","volume":"45","author":"Zhang","year":"2016","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.thromres.2026.109607_bb0120","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/jcp.25959","article-title":"Platelet-derived microparticles regulates thrombin generation via phophatidylserine in abdominal sepsis","volume":"233","author":"Wang","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.annemergmed.2006.08.021","article-title":"Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival","volume":"49","author":"Trzeciak","year":"2007","journal-title":"Ann. Emerg. Med."},{"issue":"9","key":"10.1016\/j.thromres.2026.109607_bb0130","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/01.CCM.0000138558.16257.3F","article-title":"Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock","volume":"32","author":"Sakr","year":"2004","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.thromres.2026.109607_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13613-019-0501-3","article-title":"The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis","volume":"9","author":"Cui","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.thromres.2026.109607_bb0140","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.2147\/JIR.S535701","article-title":"The crucial roles of platelets as immune mediators in sepsis","volume":"18","author":"Yang","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"10.1016\/j.thromres.2026.109607_bb0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.imbio.2012.08.268","article-title":"Polyvalent immunoglobulin significantly attenuated the formation of IL-1\u03b2 in Escherichia coli-induced sepsis in pigs","volume":"218","author":"Barratt-Due","year":"2013","journal-title":"Immunobiology"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:47:47Z","timestamp":1793630867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S0049384826000265"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109607","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgM-enriched immunoglobulin treatment significantly improves coagulation dysbalance in an experimental animal model of fulminant sepsis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109607"}}